Laura Hidalgo

1.0k total citations
32 papers, 795 citations indexed

About

Laura Hidalgo is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Laura Hidalgo has authored 32 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Immunology and 9 papers in Oncology. Recurrent topics in Laura Hidalgo's work include Antibiotic Resistance in Bacteria (7 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (6 papers). Laura Hidalgo is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (6 papers). Laura Hidalgo collaborates with scholars based in Spain, France and United Kingdom. Laura Hidalgo's co-authors include Rosa Sacedón, Ángeles Vicente, Alberto Varas, Víctor G. Martínez, Bruno González‐Zorn, Jaris Valencia, José Antonio Escudero, Carmen Hernández‐López, Belén Gutiérrez‐Gutiérrez and Álvaro San Millán and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Laura Hidalgo

31 papers receiving 781 citations

Peers

Laura Hidalgo
Zhizhou Kuang United States
Jennifer E. Oyler United States
Stephanie M. Rangel United States
Nikki J. Wagner United States
Steven A. Dunham United States
Susan R. Heimer United States
Laura Hidalgo
Citations per year, relative to Laura Hidalgo Laura Hidalgo (= 1×) peers Yanbing Ma

Countries citing papers authored by Laura Hidalgo

Since Specialization
Citations

This map shows the geographic impact of Laura Hidalgo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Hidalgo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Hidalgo more than expected).

Fields of papers citing papers by Laura Hidalgo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Hidalgo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Hidalgo. The network helps show where Laura Hidalgo may publish in the future.

Co-authorship network of co-authors of Laura Hidalgo

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Hidalgo. A scholar is included among the top collaborators of Laura Hidalgo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Hidalgo. Laura Hidalgo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hidalgo, Laura, et al.. (2025). Liposomal-Based Nanoarchitectonics as Bispecific T Cell Engagers in Neuroblastoma Therapy. ACS Applied Materials & Interfaces. 17(8). 11937–11945. 2 indexed citations
2.
Morales‐Molina, Álvaro, et al.. (2024). Deletion of the RGD motif from the penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapy. SHILAP Revista de lepidopterología. 32(3). 200863–200863. 1 indexed citations
3.
Martín-Antonio, Beatriz, Belén Blanco, África González‐Murillo, et al.. (2024). Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations. Frontiers in Immunology. 15. 1386856–1386856. 10 indexed citations
4.
Hidalgo, Laura, et al.. (2024). LIN28 upregulation in primary human T cells impaired CAR T antitumoral activity. Frontiers in Immunology. 15. 1462796–1462796.
5.
Hidalgo, Laura, et al.. (2023). Switchable CAR T cell strategy against osteosarcoma. Cancer Immunology Immunotherapy. 72(8). 2623–2633. 20 indexed citations
6.
Valencia, Jaris, Eva Jiménez, Víctor G. Martínez, et al.. (2017). Characterization of human fibroblastic reticular cells as potential immunotherapeutic tools. Cytotherapy. 19(5). 640–653. 16 indexed citations
7.
Martínez, Víctor G., Rosa Sacedón, Laura Hidalgo, et al.. (2015). The BMP Pathway Participates in Human Naive CD4+ T Cell Activation and Homeostasis. PLoS ONE. 10(6). e0131453–e0131453. 33 indexed citations
8.
Varas, Alberto, Jaris Valencia, Fabien Lavocat, et al.. (2015). Blockade of bone morphogenetic protein signaling potentiates the pro-inflammatory phenotype induced by interleukin-17 and tumor necrosis factor-α combination in rheumatoid synoviocytes. Arthritis Research & Therapy. 17(1). 192–192. 27 indexed citations
9.
Martínez, Víctor G., Laura Hidalgo, Jaris Valencia, et al.. (2015). A discrete population of IFN λ‐expressing BDCA3hi dendritic cells is present in human thymus. Immunology and Cell Biology. 93(7). 673–678. 5 indexed citations
10.
Robson, Neil C., Laura Hidalgo, Heng Wei, et al.. (2014). Optimal Effector Functions in Human Natural Killer Cells Rely upon Autocrine Bone Morphogenetic Protein Signaling. Cancer Research. 74(18). 5019–5031. 21 indexed citations
11.
Valencia, Jaris, Víctor G. Martínez, Laura Hidalgo, et al.. (2014). Wnt5a signaling increases IL-12 secretion by human dendritic cells and enhances IFN-γ production by CD4+ T cells. Immunology Letters. 162(1). 188–199. 37 indexed citations
12.
Hidalgo, Laura, Belén Gutiérrez‐Gutiérrez, Cristina M. Ovejero, et al.. (2013). Klebsiella pneumoniae Sequence Type 11 from Companion Animals Bearing ArmA Methyltransferase, DHA-1 β-Lactamase, and QnrB4. Antimicrobial Agents and Chemotherapy. 57(9). 4532–4534. 43 indexed citations
13.
Escudero, José Antonio, Álvaro San Millán, Belén Gutiérrez‐Gutiérrez, et al.. (2011). Fluoroquinolone Efflux in Streptococcus suis Is Mediated by SatAB and Not by SmrA. Antimicrobial Agents and Chemotherapy. 55(12). 5850–5860. 28 indexed citations
14.
Hidalgo, Laura, Víctor G. Martínez, Jaris Valencia, et al.. (2011). Expression of BMPRIA on human thymic NK cell precursors: role of BMP signaling in intrathymic NK cell development. Blood. 119(8). 1861–1871. 27 indexed citations
15.
Millán, Álvaro San, Maria Giufrè, José Antonio Escudero, et al.. (2010). Contribution of ROB-1 and PBP3 mutations to the resistance phenotype of a β-lactamase-positive amoxicillin/clavulanic acid-resistant Haemophilus influenzae carrying plasmid pB1000 in Italy. Journal of Antimicrobial Chemotherapy. 66(1). 96–99. 16 indexed citations
16.
Hopkins, Katie L., José Antonio Escudero, Laura Hidalgo, & Bruno González‐Zorn. (2010). 16S rRNA Methyltransferase RmtC inSalmonella entericaSerovar Virchow. Emerging infectious diseases. 16(4). 712–715. 25 indexed citations
17.
Hernández‐López, Carmen, Alberto Varas, Rosa Sacedón, et al.. (2010). The CXCL12/CXCR4 Pair in Aged Human Thymus. NeuroImmunoModulation. 17(3). 217–220. 7 indexed citations
18.
Varas, Alberto, Rosa Sacedón, Laura Hidalgo, et al.. (2009). Interplay between BMP4 and IL-7 in human intrathymic precursor cells. Cell Cycle. 8(24). 4119–4126. 19 indexed citations
19.
Gutiérrez‐Gutiérrez, Belén, Laura Herrera, José Antonio Escudero, et al.. (2009). Novel genetic environment of qnrB2 associated with TEM-1 and SHV-12 on pB1004, an IncHI2 plasmid, in Salmonella Bredeney BB1047 from Spain. Journal of Antimicrobial Chemotherapy. 64(6). 1334–1336. 13 indexed citations
20.
Varas, Alberto, Carmen Hernández‐López, Jaris Valencia, et al.. (2008). Survival and function of human thymic dendritic cells are dependent on autocrine Hedgehog signaling. Journal of Leukocyte Biology. 83(6). 1476–1483. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026